SYMAR (formerly OpinioAI) vs Elicit

SYMAR (formerly OpinioAI) lets insights, marketing, and product teams run surveys, focus groups, and one-on-one interviews with AI-built respondent personas instead of live panels. You define segments by demographics, psychographics, and buying behavior, then deploy studies through a web workspace at app.symar.ai. Results arrive in hours rather than the two to six weeks typical panel studies need.

Where traditional research vendors sell access to real people, SYMAR simulates them. Personas carry synthetic memory, so they recall prior exposures and support longitudinal studies. Focus groups run with an AI moderator that asks follow-ups and manages group dynamics. The vendor positions this for early validation and iteration, not as a wholesale replacement for human panels on final, high-stakes decisions.

Product marketers, UX researchers, and strategy teams use it to test messaging, creative assets, and concept appeal before committing panel budgets. C+R Research, Belkin, and Kentico appear in published customer stories on symar.ai. Pricing starts at $119 per month on the Project tier with a 400-credit monthly cap.

Elicit is a research assistant built for scientists, analysts, and policy teams who need cited answers from academic literature rather than generic chatbot summaries. It searches more than 138 million academic papers and 545,000 clinical trials, then returns evidence with sentence-level citations tied to the underlying sources. The platform covers paper search, research reports, systematic literature reviews, a research agent for multi-step workflows, a personal library, and alerts for new publications.

Where general AI chat tools guess at scientific claims, Elicit anchors every statement to a specific passage, table, or figure from the source material. Its semantic search finds relevant papers even when keyword overlap is thin, and it can screen and analyze up to 1,000 papers in a single workflow. That focus on traceable evidence over fluent prose is what separates it from tools like ChatGPT or Perplexity for high-stakes research decisions.

Elicit serves academic researchers, pharmaceutical teams, medical device companies, and government policy groups. Formation Bio, Oxford PharmaGenesis, and VDI/VDE have published case studies using Elicit for systematic reviews, data extraction, and literature screening at scale. The free Basic plan covers unlimited search and summaries, while paid tiers unlock systematic review workflows, API access, and team collaboration.